BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38095019)

  • 21. Beyond Type 1 Regulatory T Cells: Co-expression of LAG3 and CD49b in IL-10-Producing T Cell Lineages.
    Huang W; Solouki S; Carter C; Zheng SG; August A
    Front Immunol; 2018; 9():2625. PubMed ID: 30510554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.
    Helmsauer K; Valieva ME; Ali S; Chamorro González R; Schöpflin R; Röefzaad C; Bei Y; Dorado Garcia H; Rodriguez-Fos E; Puiggròs M; Kasack K; Haase K; Keskeny C; Chen CY; Kuschel LP; Euskirchen P; Heinrich V; Robson MI; Rosswog C; Toedling J; Szymansky A; Hertwig F; Fischer M; Torrents D; Eggert A; Schulte JH; Mundlos S; Henssen AG; Koche RP
    Nat Commun; 2020 Nov; 11(1):5823. PubMed ID: 33199677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
    Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
    Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CG hypomethylation in Lsh-/- mouse embryonic fibroblasts is associated with de novo H3K4me1 formation and altered cellular plasticity.
    Yu W; Briones V; Lister R; McIntosh C; Han Y; Lee EY; Ren J; Terashima M; Leighty RM; Ecker JR; Muegge K
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5890-5. PubMed ID: 24711395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A four-stage model for murine natural killer cell development in vivo.
    Ma S; Caligiuri MA; Yu J
    J Hematol Oncol; 2022 Mar; 15(1):31. PubMed ID: 35313938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model.
    Waldeck K; Cullinane C; Ardley K; Shortt J; Martin B; Tothill RW; Li J; Johnstone RW; McArthur GA; Hicks RJ; Wood PJ
    Int J Cancer; 2016 Jul; 139(1):194-204. PubMed ID: 26914605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.
    Lee JE; Wang C; Xu S; Cho YW; Wang L; Feng X; Baldridge A; Sartorelli V; Zhuang L; Peng W; Ge K
    Elife; 2013 Dec; 2():e01503. PubMed ID: 24368734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone H3K4me1 strongly activates the DNase I hypersensitive sites in super-enhancers than those in typical enhancers.
    Kang Y; Kang J; Kim A
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34195788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic plasticity of enhancers in cancer.
    Yao J; Chen J; Li LY; Wu M
    Transcription; 2020 Feb; 11(1):26-36. PubMed ID: 31944157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.
    Yan J; Chen SA; Local A; Liu T; Qiu Y; Dorighi KM; Preissl S; Rivera CM; Wang C; Ye Z; Ge K; Hu M; Wysocka J; Ren B
    Cell Res; 2018 Feb; 28(2):204-220. PubMed ID: 29313530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of regulatory elements during erythro-megakaryopoiesis identifies hematopoietic lineage-commitment points.
    Heuston EF; Keller CA; Lichtenberg J; Giardine B; Anderson SM; ; Hardison RC; Bodine DM
    Epigenetics Chromatin; 2018 May; 11(1):22. PubMed ID: 29807547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RBBP4 dysfunction reshapes the genomic landscape of H3K27 methylation and acetylation and disrupts gene expression.
    Mu W; Murcia NS; Smith KN; Menon DU; Yee D; Magnuson T
    G3 (Bethesda); 2022 May; 12(6):. PubMed ID: 35416979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD49b-dependent establishment of T helper cell memory.
    Hanazawa A; Hayashizaki K; Shinoda K; Yagita H; Okumura K; Löhning M; Hara T; Tani-ichi S; Ikuta K; Eckes B; Radbruch A; Tokoyoda K; Nakayama T
    Immunol Cell Biol; 2013 Sep; 91(8):524-31. PubMed ID: 23897120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone H3 lysine 4 monomethylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycaemic/hyperinsulinemic conditions in 3T3 cells.
    Gupta J; Kumar S; Li J; Krishna Murthy Karuturi R; Tikoo K
    Biochimie; 2012 Dec; 94(12):2656-64. PubMed ID: 22951486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn.
    Kobayashi K; Jakt LM; Nishikawa SI
    Oncogene; 2013 May; 32(21):2640-8. PubMed ID: 22751132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.
    Henssen A; Althoff K; Odersky A; Beckers A; Koche R; Speleman F; Schäfers S; Bell E; Nortmeyer M; Westermann F; De Preter K; Florin A; Heukamp L; Spruessel A; Astrahanseff K; Lindner S; Sadowski N; Schramm A; Astorgues-Xerri L; Riveiro ME; Eggert A; Cvitkovic E; Schulte JH
    Clin Cancer Res; 2016 May; 22(10):2470-81. PubMed ID: 26631615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
    Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes.
    Narita T; Higashijima Y; Kilic S; Liebner T; Walter J; Choudhary C
    Nat Genet; 2023 Apr; 55(4):679-692. PubMed ID: 37024579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers.
    Soldi M; Mari T; Nicosia L; Musiani D; Sigismondo G; Cuomo A; Pavesi G; Bonaldi T
    Nucleic Acids Res; 2017 Dec; 45(21):12195-12213. PubMed ID: 28981749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.